AC Immune SA - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAC Immune SA

AC Immune SA(ACIU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Fluorodopa f-18

healthy volunteers/patients

,

parkinson disease

,

multiple system atrophy

,

lewy body disease

,

,

synucleinopathies

,

progressive supranuclear palsy

,

corticobasal degeneration

allergic rhinitis seasonal

,

nasal obstruction

,

,

,

restless legs syndrome

,

spinal cord injuries

,

type 1 diabetes mellitus

,

,

non-small-cell lung carcinoma

,

,

breast neoplasms

,

,

neurologic manifestations

,

wounds and injuries

,

central nervous system diseases

,

spinal cord diseases

,

sleep wake disorders

,

inguinal hernia

,

peripheral nervous system diseases

,

,

,

,

healthy volunteers/patients

,

,

partial epilepsies

,

diabetic neuropathies

,

,

,

sleep initiation and maintenance disorders

,

,

postherpetic neuralgia

,

postoperative pain

,

anxiety disorders

,

,

generalized anxiety disorder

,

complex partial epilepsy

,

,

,

bronchiolitis obliterans syndrome

,

,

,

intractable pain

,

,

,

renal insufficiency

,

pharmacovigilance

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use